John Feigert
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Iron Metabolism and Disorders
- Genetics top 5%
- Hemoglobinopathies and Related Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Genetics 4
- Hemoglobinopathies and Related Disorders 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- Acute Myeloid Leukemia Research 4
- Co-authors
- Maria R. Baer (4 shared papers)Carole Paley (4 shared papers)Emmanuel C. Besa (4 shared papers)Jason Esposito (4 shared papers)Azra Raza (4 shared papers)Alan F. List (4 shared papers)David P. Steensma (4 shared papers)Chao Yin (1 shared paper)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (1 paper)Annals of Internal Medicine (1 paper)Journal of Oncology Practice (1 paper)BMJ Case Reports (1 paper)
- Partner nations
- United States
In The Last Decade
John Feigert
7 papers receiving 233 citations
Peers
Comparison fields: 5 of 37
- Hematology 187
- Genetics 166
- Orthopedics and Sports Medicine 15
- Neurology 20
- Pathology and Forensic Medicine 19
Countries citing papers authored by John Feigert
This map shows the geographic impact of John Feigert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Feigert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Feigert more than expected).
Fields of papers citing papers by John Feigert
This network shows the impact of papers produced by John Feigert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Feigert. The network helps show where John Feigert may publish in the future.
Co-authors
The 8 scholars most cited alongside John Feigert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 141 | |
| 2 | 1990 | 34 | |
| 3 | 2008 | 24 | |
| 4 | 2007 | 20 | |
| 5 | 2009 | 11 | |
| 6 | 2010 | 6 | |
| 7 | 2019 | 3 |
About John Feigert
John Feigert is a scholar working on Genetics, Hematology, Surgery, Pathology and Forensic Medicine and General Health Professions, having authored 7 papers that have together received 239 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (4 papers), Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Lymphadenopathy Diagnosis and Analysis (1 paper), Health Policy Implementation Science (1 paper), Clinical practice guidelines implementation (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). The work is most often cited by research in Hematology (187 citations), Genetics (166 citations), Orthopedics and Sports Medicine (15 citations), Neurology (20 citations) and Pathology and Forensic Medicine (19 citations). John Feigert has collaborated with scholars based in United States. Frequent co-authors include Maria R. Baer, Carole Paley, Emmanuel C. Besa, Jason Esposito, Azra Raza, Alan F. List, David P. Steensma and Chao Yin. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Internal Medicine, Journal of Oncology Practice and BMJ Case Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.